Medicines Australia has announced the establishment of an expert interest group focused on radiopharmaceuticals, comprising members from across its membership.
-
Latest News
New immunisation strategy highlights COVID impact, priority patients and new technologies
Health Minister Mark Butler has launched Australia's new National Immunisation Strategy 2025–30, with a focus on priority populations, strengthening emergency preparedness, and harnessing vaccine technologies.
-
Latest News Medicines Australia establishes radiopharmaceuticals working group June 12, 2025
-
Latest News Novo Nordisk partners with Heart of Australia to expand clinical trial access June 12, 2025Novo Nordisk has announced a partnership with mobile healthcare delivery provider Heart of Australia to bring more clinical trial opportunities to regional, rural and remote communities in Queensland.
-
Latest News Specialised Therapeutics expands partnership with Incyte to include two additional therapies June 13, 2025Specialised Therapeutics has announced the expansion of its existing supply and distribution agreement with Incyte to launch and distribute two additional medicines from its oncology portfolio in Australia, New Zealand and Singapore.
-
Latest News MSD Australia and New Zealand certified a 'Great Place to Work' June 12, 2025MSD Australia and MSD New Zealand have been recognised with the certified status by Great Place to Work for 2025 for a second consecutive year.
-
Latest News What will the HTA Review Implementation Advisory Group do if the PBAC rejects the process? June 11, 2025What will the HTA Review Implementation Advisory Group do if the PBAC rejects the streamlined process? The question should also be phrased differently. How will the HTA Review's IAG respond if the PBAC recommends the proposal?
-
Latest News Pfizer chief sets out the potential implications of 'Most Favored Nation' pricing June 11, 2025In response to a question about the risk of removing products from reimbursement in some countries to protect the US market, Pfizer Chief Executive and PhRMA Chair Dr Albert Bourla said, "I think yes."
-
Latest News Mark Butler starts the process of NDIS pricing reform June 11, 2025As Mark Butler starts leading the process of integrating the NDIS into his portfolio, the review has revealed that the program's pricing limits are out of step with broader market rates, in some cases exceeding them by up to 68 per cent.
-
Latest News Medicines Australia says delayed listings would not be a surprising response June 10, 2025Medicines Australia says it has not heard from companies that they have placed ‘the brake on’ ex-US pricing outcomes in response to the US Most Favored Nation pricing executive order, but added that "this would not be a surprising response."
-
Latest News New study reveals superior efficacy of cell-based flu vaccine June 10, 2025New data presented today at the Public Health Association of Australia's Communicable Diseases and Immunisation Conference have shown that cell-based influenza vaccines were nearly 20 per cent more effective at preventing test-confirmed infections compared to traditional standard-dose egg-based vaccines.
-
Latest News Advocacy group 'pleading' with the NSW Government to establish Men B vaccine program June 10, 2025Meningitis Centre Australia says it is "pleading" with the New South Wales Government to fund a Meningococcal B vaccination program for babies and teens in its upcoming budget.
-
Latest News Companies confirm renewed push for streamlined immunotherapy listing process June 9, 2025The Pharmaceutical Benefits Advisory Committee will consider new proposals from MSD and Bristol Myers Squibb at its July meeting to accelerate reimbursement of approved indications for their immunotherapies.
-
Latest News You certainly couldn't accuse this system of haste, and this might need ministerial intervention June 9, 2025Credit to the companies for persisting, given that the Pharmaceutical Benefits Advisory Committee has considered streamlining the reimbursement of immunotherapies for much of the past eight years.
-
Latest News Early intervention on chronic kidney disease would deliver economic boost June 8, 2025Ben McDonald, the country president of AstraZeneca Australia and New Zealand, stated that the findings demonstrate the opportunity Australia has to reduce the health and economic burden of chronic kidney disease.
-
Latest News Australian Dementia Network, Monash University and Lilly sign research collaboration June 6, 2025"This project exemplifies our dedication to uniting with key stakeholders in the Alzheimer's community to drive forward groundbreaking research and innovative treatments,” said Vinay Prusty, the executive director of medical neuroscience at Lilly.
-
Latest News 'My experience was awful, I really had to fight to be taken seriously and advocate for myself' June 5, 2025Rare Cancers Australia has launched a campaign to raise awareness of the patient impact ahead of Rare Cancers Australia Day in late June.
-
Podcast The Dispatched Podcast - 6 June June 6, 2025Adding disability to health in an already full ministerial bandwidth and funding challenges. Trade policy and the PBS, and a presentation on the human consequences of our decision-making. Is a targeted diagnostic screening and the strangest patient case study?
-
Latest News UK moves to pricing changes as Australian-based companies baulk at listings June 5, 2025Reports suggest that the UK government has agreed to pay higher prices for prescription medicines, with the suggestion that this is a response to a demand from the US Trump administration. Meanwhile, some companies in Australia have paused the progression of PBS listings in response to MFN uncertainty.
-
Latest News Health department amends published blood review information June 5, 2025The Department of Health, Disability and Ageing has amended its published update on the review of National Blood Arrangements following alarm at the inclusion of specific funding decisions on individual products.
-
Latest News AusBiotech and Austrade launch partnership to accelerate global expansion of life sciences industry June 4, 2025AusBiotech and the Australian Government's Trade and Investment Commission, Austrade, are partnering to accelerate the global growth and expansion of life science companies.
Australian Biotech
-
Clarity announces positive top-line results from DISCO trial
June 5, 2025 -
Clinical trial success kicks off $5m fund-raising round for WA’s Lixa
June 5, 2025 -
AusBiotech and Austrade launch partnership to accelerate global expansion of life sciences industry
June 4, 2025 -
Australian innovation could revolutionise the early detection of ovarian cancer
June 2, 2025 -
AusBiotech welcomes shadow ministry and encourages bipartisan support for life sciences sector
June 2, 2025
Other Health
-
Kidney Health Australia urges those at risk to get checked
March 10, 2025 -
Sepsis survivors at high risk after hospital discharge, new figures reveal
March 5, 2025 -
New Zealand medtech start-up Avasa hits milestone in development of world’s first arterial coupler
February 24, 2025 -
Australia isn’t ready for the next cardiac epidemic, warns landmark heart valve disease report
February 17, 2025 -
BTC announced new partnership agreement with Corcym
December 9, 2024
Latest Video
New Stories
-
Specialised Therapeutics expands partnership with Incyte to include two additional therapies
June 13, 2025 - - Latest News -
New immunisation strategy highlights COVID impact, priority patients and new technologies
June 12, 2025 - - Latest News -
Medicines Australia establishes radiopharmaceuticals working group
June 12, 2025 - - Latest News -
MSD Australia and New Zealand certified a 'Great Place to Work'
June 12, 2025 - - Latest News -
Specialised Therapeutics expands partnership with Incyte to include two additional therapies
June 12, 2025 - - Latest News -
Novo Nordisk partners with Heart of Australia to expand clinical trial access
June 12, 2025 - - Latest News -
Mark Butler starts the process of NDIS pricing reform
June 11, 2025 - - Latest News